Enhanced expression of human or humanized immunoglobulin in non-human transgenic animals
AssigneeTherapeutic Human Polyclonals, Inc.
InventorRoland Buelow
Life of this patent
Estimating the term…
Abstract
The present invention describes transgenic animals with human(ized) immunoglobulin loci and transgenes encoding human(ized) Igα and/or Igβ sequences. Of particular interest are animals with transgenic heavy and light chain immunoglobulin loci capable of producing a diversified human(ized) antibody repertoire that have their endogenous production of Ig and/or endogenous Igα and/or Igβ sequences suppressed. Simultaneous expression of human(ized) immunoglobulin and human(ized) Igα and/or Igβ results in normal B-cell development, affinity maturation and efficient expression of human(ized) antibodies.
Claims2
A method for isolating B-cells producing a human Igα or a human Igβ subunit in a transgenic rabbit, comprising the steps of:
- (a) microinjecting into pronuclear-stage zygotes, which were collected from an oviduct of a superovulated female rabbit that had been mated with a male rabbit, an expression vector for expression of a native full-length human Igα subunit of SEQ ID NO:
- 1 under control of a B-cell specific promoter/enhancer of CD79a or a native full-length human Igβ subunit of SEQ ID NO:
- 7 under control of a B-cell specific promoter/enhancer of CD79B;
- (b) transferring morphological surviving zygotes to the oviducts of pseudopregnant rabbits;
- (c) developing the injected zygotes into live transgenic rabbits;
- (d) subjecting the live transgenic rabbit to an antigenic stimulus;
- and
- (e) isolating B-cells producing said human Igα or human Igβ from the live transgenic rabbit of step (d).
Dependencies are inferred from the claim text.